Table 6.
Association between YAP expression in NSCLC tissues and clinical features
| Clinicopathologic feature | n | AXL | χ 2 | P | |
|---|---|---|---|---|---|
|
| |||||
| Low | High | ||||
| Age | 1.61 | 0.2045 | |||
| < 60 | 27 | 9 (25.71%) | 18 (39.13%) | ||
| ≥ 60 | 54 | 26 (74.29%) | 28 (60.87%) | ||
| Gender | 1.13 | 0.2884 | |||
| Male | 60 | 28 (80.00%) | 32 (69.57%) | ||
| Female | 21 | 7 (20.00%) | 14 (30.43%) | ||
| Differentiation | 18.54 | < .0001 | |||
| Medium-well differentiated | 38 | 26 (74.29%) | 12 (26.09%) | ||
| Poorly differentiated | 43 | 9 (25.71%) | 34 (73.91%) | ||
| Histologic type | 0.00 | 0.9470 | |||
| Squamous carcinoma | 42 | 18 (51.43%) | 24 (52.17%) | ||
| Adenocarcinoma | 39 | 17 (48.57%) | 22 (47.83%) | ||
| T stage | 4.08 | < .0001 | |||
| T1 | 12 | 8 (22.86%) | 4 (8.70%) | ||
| T2 | 44 | 25 (71.43%) | 19 (41.30%) | ||
| T3 | 18 | 2 (5.71%) | 16 (34.78%) | ||
| T4 | 7 | 0 (0.00%) | 7 (15.22%) | ||
| Pathological TNM stage | 6.95 | < .0001 | |||
| I | 35 | 30 (85.71%) | 5 (10.87%) | ||
| II | 11 | 4 (11.43%) | 7 (15.22%) | ||
| III | 35 | 1 (2.86%) | 34 (73.91%) | ||
| IV | 0 | 0 (0.00%) | 0 (0.00%) | ||